# AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy

> **NCT03493607** · PHASE2 · COMPLETED · sponsor: **Alexander Kolevzon** · enrollment: 6 (actual)

## Conditions studied

- Phelan-McDermid Syndrome
- Epilepsy

## Interventions

- **DRUG:** AMO-01

## Key facts

- **NCT ID:** NCT03493607
- **Lead sponsor:** Alexander Kolevzon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-30
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493607, "AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03493607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*